TY - JOUR
T1 - Mef2c factors are required for early but not late addition of cardiomyocytes to the ventricle
AU - Kula-Alwar, Duvaraka
AU - Marber, Michael
AU - Hughes, Simon
AU - Hinits, Yaniv
N1 - Funding Information:
We thank Jeroen Bakkers and Didier Stainier for transgenic lines. DK was supported by the PhD programme of the British Heart Foundation Centre of Research Excellence at King's College London. SMH is a member of MRC Scientific Staff with Programme Grant G1001029 and MR/N021231/1 support. YH was supported by British Heart Foundation Project Grant PG/14/12/30664.
Funding Information:
We thank Jeroen Bakkers and Didier Stainier for transgenic lines. DK was supported by the PhD programme of the British Heart Foundation Centre of Research Excellence at King’s College London. SMH is a member of MRC Scientific Staff with Programme Grant G1001029 and MR/N021231/1 support. YH was supported by British Heart Foundation Project Grant PG/14/12/30664 .
Publisher Copyright:
© 2020 The Authors
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/2
Y1 - 2021/2
N2 - During heart formation, the heart grows and undergoes dramatic morphogenesis to achieve efficient embryonic function. Both in fish and amniotes, much of the growth occurring after initial heart tube formation arises from second heart field (SHF)-derived progenitor cell addition to the arterial pole, allowing chamber formation. In zebrafish, this process has been extensively studied during embryonic life, but it is unclear how larval cardiac growth occurs beyond 3 days post-fertilisation (dpf). By quantifying zebrafish myocardial growth using live imaging of GFP-labelled myocardium we show that the heart grows extensively between 3 and 5 dpf. Using methods to assess cell division, cellular development timing assay and Kaede photoconversion, we demonstrate that proliferation, CM addition, and hypertrophy contribute to ventricle growth. Mechanistically, we show that reduction in Mef2c activity (mef2ca+/-;mef2cb-/-), downstream or in parallel with Nkx2.5 and upstream of Ltbp3, prevents some CM addition and differentiation, resulting in a significantly smaller ventricle by 3 dpf. After 3 dpf, however, CM addition in mef2ca+/-;mef2cb-/- mutants recovers to a normal pace, and the heart size gap between mutants and their siblings diminishes into adulthood. Thus, as in mice, there is an early time window when SHF contribution to the myocardium is particularly sensitive to loss of Mef2c activity.
AB - During heart formation, the heart grows and undergoes dramatic morphogenesis to achieve efficient embryonic function. Both in fish and amniotes, much of the growth occurring after initial heart tube formation arises from second heart field (SHF)-derived progenitor cell addition to the arterial pole, allowing chamber formation. In zebrafish, this process has been extensively studied during embryonic life, but it is unclear how larval cardiac growth occurs beyond 3 days post-fertilisation (dpf). By quantifying zebrafish myocardial growth using live imaging of GFP-labelled myocardium we show that the heart grows extensively between 3 and 5 dpf. Using methods to assess cell division, cellular development timing assay and Kaede photoconversion, we demonstrate that proliferation, CM addition, and hypertrophy contribute to ventricle growth. Mechanistically, we show that reduction in Mef2c activity (mef2ca+/-;mef2cb-/-), downstream or in parallel with Nkx2.5 and upstream of Ltbp3, prevents some CM addition and differentiation, resulting in a significantly smaller ventricle by 3 dpf. After 3 dpf, however, CM addition in mef2ca+/-;mef2cb-/- mutants recovers to a normal pace, and the heart size gap between mutants and their siblings diminishes into adulthood. Thus, as in mice, there is an early time window when SHF contribution to the myocardium is particularly sensitive to loss of Mef2c activity.
KW - zebrafish
KW - second heart field
KW - mef2c
KW - cardiomyocyte
KW - growth
UR - http://www.scopus.com/inward/record.url?scp=85097103028&partnerID=8YFLogxK
U2 - 10.1016/j.ydbio.2020.11.008
DO - 10.1016/j.ydbio.2020.11.008
M3 - Article
C2 - 33245870
SN - 0012-1606
VL - 470
SP - 95
EP - 107
JO - Developmental Biology
JF - Developmental Biology
ER -